Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Senti Biosciences (SNTI) EPS (Basic) (2021 - 2025)

Senti Biosciences (SNTI) has 5 years of EPS (Basic) data on record, last reported at -$0.69 in Q3 2025.

  • For Q3 2025, EPS (Basic) rose 89.06% year-over-year to -$0.69; the TTM value through Sep 2025 reached -$2.9, up 81.4%, while the annual FY2024 figure was -$12.03, 36.01% up from the prior year.
  • EPS (Basic) reached -$0.69 in Q3 2025 per SNTI's latest filing, down from -$0.18 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $0.92 in Q2 2022 and bottomed at -$8.16 in Q2 2023.
  • Average EPS (Basic) over 5 years is -$1.99, with a median of -$1.01 recorded in 2025.
  • Peak YoY movement for EPS (Basic): surged 3166.67% in 2022, then tumbled 2358.82% in 2023.
  • A 5-year view of EPS (Basic) shows it stood at -$1.32 in 2021, then soared by 87.16% to -$0.17 in 2022, then crashed by 2358.82% to -$4.18 in 2023, then skyrocketed by 85.17% to -$0.62 in 2024, then decreased by 11.29% to -$0.69 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Basic) were -$0.69 in Q3 2025, -$0.18 in Q2 2025, and -$1.41 in Q1 2025.